Navigation Links
Drug May Help Reverse Clotting Deficiency
Date:11/28/2007

- used to fight hepatitis C -- was successfully completed by 36 percent, 53 percent and 65 percent of patients receiving 30 milligrams, 50 milligrams or 75 milligrams of eltrombopag, and only 6 percent of those in the placebo group.

"We deal with people on the [liver] transplant list with low platelet counts all the time. We've never had a drug we could give them, particularly by mouth," McHutchison said.

Two larger trials are planned which, if successful, could form the basis for FDA approval of the drug, the researchers said.

More information

There's more on ITP at the U.S. National Heart, Lung and Blood Institute .



SOURCES: John G. McHutchison, M.D., associate director, Duke Clinical Research Institute, and professor of medicine, Duke University, Durham, N.C.; Robert S. Schwartz, M.D., deputy editor, The New England Journal of Medicine, Boston; Nov. 29, 2007, New England Journal of Medicine


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. U of M study: Early treatment can reverse heart damage
2. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
3. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
4. Combination therapy reverses effects of portal hypertension in rats
5. Biopure Announces Reverse Stock Split
6. Aggressively Treating Cardiac Risk Factors May Reverse Ischemia
7. All-State Properties, L.P. Announces Termination of Reverse Merger With Chinese Pharmaceutical Company
8. itLinkz Group, Inc. Changes Name to China YCT International Group, Inc. and Effects Reverse Stock Split
9. Possible safer target for anti-clotting drugs found
10. Anticlotting drug found to be safe in sickle cell patients
11. FDA to Review Clotting Drug After Trial Suggests Death Risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug May Help Reverse Clotting Deficiency
Drug May Help Reverse Clotting Deficiency
(Date:5/21/2008)...y 21 /PRNewswire-FirstCall/ -- Aflac Incorporated,...presentation at the Sanford,C. Bernstein & Co., LL...nce,2008., President and Chief Financial Officer ...ted, and he is scheduled to make a presentation on...orated presentation, Mr.,Cloninger will discuss th...
(Date:5/21/2008)...d SILVER SPRING, Md., May 21 /PRNewswire-USNewswir... (ADAA),( http://www.adaa.org ) and The HealthCent... announced that ADAA will join,HealthCentral,s gro...and,health experts dedicated to helping people suf... advice and support they need to cope with the,con...
(Date:5/21/2008)...s 1st quarter profit, enhanced operations and new ...ELES, May 21 /PRNewswire-FirstCall/ -- InstaCare C...butor of at-home testing diagnostics,for the chron...eveloper of,patent-pending technologies for e-heal...s for the first quarter period-ended March 31, 200...
(Date:5/21/2008)... Adverse Events in TORCH Showed Frequency Highest ...ONTO and RESEARCH TRIANGLE PARK, N.C., May 21 /PRN...500/50 (fluticasone propionate and,salmeterol inha...er of,cardiovascular adverse events compared to ot...from the TOwards a Revolution in COPD Health,(TORC...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 2Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 3
...ans – The manner with which an individual responds...an the chronological age, say leading researchers ...rinology. // Healthy aging is all about handling s...estyle. From a review of studies on how stress h...
...ers have explained that the killer disease of H.In...routinely vaccinating the infants Hib vaccine. // ...in their research that the routine vaccination of ...Type b (Hib) significantly reduced invasive Hib di...
...d Health Organisation (WHO), the UN Food and Agric...on of Animal Health (OAH) have decided to set up a...s of zoonoses // , or the diseases that are transm...ystem has become imperative since bird flu, SARS a...
...drome can also cause problems in men, according to...ett Syndrome Study at the Telethon Institute for C...t genetic testing to detect the disease in baby bo...inking in the past had been that Rett syndrome onl...
Other Medicine News:Health News:Studying the psycho neurobiology of aging 2Health News:Studying the psycho neurobiology of aging 3Health News:Researchers claim That Regular Use Of Hib Vaccine In Africa Could Eliminate H. Influenza totally. 2Health News:Researchers claim That Regular Use Of Hib Vaccine In Africa Could Eliminate H. Influenza totally. 3Health News:Rett Syndrome In Men? 2
(Date:5/20/2008)... SEATTLE, May 20 /- Ome...patient enrollment for the Phase 1 study of,OMS201...oduct candidate,for use during urological surgery...roscopic removal of stones with a maximum diameter...r ureter will be enrolled in the,study., "Advanci...
(Date:5/20/2008)... - Study shows significantly improved bronchodil...th combination therapy -, NAPA, Calif., May 20 /P...a demonstrating that patients with Chronic Obstruc... and chronic bronchitis, experienced markedly,impr...ted with a,combination of nebulized formoterol fum...
(Date:5/20/2008)... A Separate Retrospective Analysis of US Employer...Factor Therapies on Absenteeism Among Employees wi...e, SAN DIEGO, May 20 /- Data from a ...ls (ACT 1 and ACT 2) showed that at week 8,more t...rely active,ulcerative colitis (UC) receiving REMI...
(Date:5/20/2008)... Data Presented at the 2008 International Conf...Thoracic Society, TORONTO, May 20 /PRNewswire-Fir...ios Almirall, S.A. today presented results from fo...ty of aclidinium bromide, an,investigational treat...PD).,Data from four preclinical studies further de...
Breaking Medicine Technology:Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study 2Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 2Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 3Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 4Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 5Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 6Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 7New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 2New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 3New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 4New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 5New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 6New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 7New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 8Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 2Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 3Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 4Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 5Kristin Chenoweth to Perform Benefit Concert for 3 Angels Memorial Fund titled Kristin Chenoweth This Ones Personal 3A A Concert to Stop ACD 16531 1Kristin Chenoweth to Perform Benefit Concert for 3 Angels Memorial Fund titled Kristin Chenoweth This Ones Personal 3A A Concert to Stop ACD 16531 2Kristin Chenoweth to Perform Benefit Concert for 3 Angels Memorial Fund titled Kristin Chenoweth This Ones Personal 3A A Concert to Stop ACD 16531 3Amnis Announces Release of Powerful New Image Data Analysis Software 4526 1Amnis Announces Release of Powerful New Image Data Analysis Software 4526 2Monell scientist Mark Friedman awarded Guggenheim Fellowship to study diet and obesity 2850 1Monell scientist Mark Friedman awarded Guggenheim Fellowship to study diet and obesity 2850 2Gel Enables Severed Spinal Cord Fibers to Regrow 16522 1Gel Enables Severed Spinal Cord Fibers to Regrow 16522 2
...7 - CELSION CORPORATION,(AMEX:CLN) today announced...dy, using ThermoDox(R), to treat non-resectable li...Cooperative Research,and Development Agreement (CR...e (NCI) of the National Institutes of Health, unde...Investigator, Head,Tumor Angiogenesis Section, Su...
...NNOVIVE Pharmaceuticals,Inc. (OTCBB: IVPH) today ...f INNO-406, an orally bioavailable dual Bcr-Abl an...,treatment-intolerant chronic myelogenous leukemia...f Clinical Oncology Annual,Meeting. The meeting ta...icago, Illinois., Information related to the prese...
Other Medicine Technology:Celsion Completes Enrollment in Phase I Liver Cancer Study 2Celsion Completes Enrollment in Phase I Liver Cancer Study 3Innovive Pharmaceuticals to Present Interim Data from Phase I Study,of INNO-406 at the American Society of Clinical Oncology Annual,Meeting 2
Unique product designed for LASIK surgery and other types of refractive surgery. Designed to irrigate the corneal interface and/or stromal bed. Flattened tip provides easy insertion under the flap an
Unique product designed for LASIK surgery and other types of refractive surgery. Designed to irrigate the corneal interface and/or stromal bed. Flattened tip provides easy insertion under the flap an
For injecting viscoelastic to all meridians of the anterior chamber and to coat intraocular lenses. 20G x 7.8in (.90 x 22mm).
For administering anesthetic agents into the posterior sub-Tenon's space 20G x 1in (.90 x 25mm)
Medicine Products: